184 related articles for article (PubMed ID: 17896837)
1. Melanin-concentrating hormone receptor-1 antagonists as antiobesity therapeutics: current status.
Kowalski TJ; Sasikumar T
BioDrugs; 2007; 21(5):311-21. PubMed ID: 17896837
[TBL] [Abstract][Full Text] [Related]
2. Anti-obesity effects of small molecule melanin-concentrating hormone receptor 1 (MCHR1) antagonists.
Luthin DR
Life Sci; 2007 Jul; 81(6):423-40. PubMed ID: 17655875
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists.
Sasmal PK; Sasmal S; Rao PT; Venkatesham B; Roshaiah M; Abbineni C; Khanna I; Jadhav VP; Suresh J; Talwar R; Muzeeb S; Receveur JM; Frimurer TM; Rist Ø; Elster L; Högberg T
Bioorg Med Chem Lett; 2010 Sep; 20(18):5443-8. PubMed ID: 20724156
[TBL] [Abstract][Full Text] [Related]
4. Recent patents on novel MCH1 receptor antagonists as potential anti-obesity drugs.
Szalai KK; Beke G; Éles J; Kitka T; Kovács P; Nagy J; Farkas S; Boros A
Recent Pat CNS Drug Discov; 2014; 9(2):122-40. PubMed ID: 24924101
[TBL] [Abstract][Full Text] [Related]
5. Antiobesity effects of melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
Cheon HG
Handb Exp Pharmacol; 2012; (209):383-403. PubMed ID: 22249825
[TBL] [Abstract][Full Text] [Related]
6. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.
McBriar MD; Guzik H; Xu R; Paruchova J; Li S; Palani A; Clader JW; Greenlee WJ; Hawes BE; Kowalski TJ; O'Neill K; Spar B; Weig B
J Med Chem; 2005 Apr; 48(7):2274-7. PubMed ID: 15801820
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression.
Gehlert DR; Rasmussen K; Shaw J; Li X; Ardayfio P; Craft L; Coskun T; Zhang HY; Chen Y; Witkin JM
J Pharmacol Exp Ther; 2009 May; 329(2):429-38. PubMed ID: 19182070
[TBL] [Abstract][Full Text] [Related]
8. Identification of a nonbasic melanin hormone receptor 1 antagonist as an antiobesity clinical candidate.
Washburn WN; Manfredi M; Devasthale P; Zhao G; Ahmad S; Hernandez A; Robl JA; Wang W; Mignone J; Wang Z; Ngu K; Pelleymounter MA; Longhi D; Zhao R; Wang B; Huang N; Flynn N; Azzara AV; Barrish JC; Rohrbach K; Devenny JJ; Rooney S; Thomas M; Glick S; Godonis HE; Harvey SJ; Cullen MJ; Zhang H; Caporuscio C; Stetsko P; Grubb M; Maxwell BD; Yang H; Apedo A; Gemzik B; Janovitz EB; Huang C; Zhang L; Freeden C; Murphy BJ
J Med Chem; 2014 Sep; 57(18):7509-22. PubMed ID: 25165888
[TBL] [Abstract][Full Text] [Related]
9. Melanin concentrating hormone receptor 1 (MCHR1) antagonists-Still a viable approach for obesity treatment?
Högberg T; Frimurer TM; Sasmal PK
Bioorg Med Chem Lett; 2012 Oct; 22(19):6039-47. PubMed ID: 22954736
[TBL] [Abstract][Full Text] [Related]
10. Novel MCH1 receptor antagonists: a patent review.
Johansson A; Löfberg C
Expert Opin Ther Pat; 2015 Feb; 25(2):193-207. PubMed ID: 25522065
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity.
Kowalski TJ; McBriar MD
Expert Opin Investig Drugs; 2004 Sep; 13(9):1113-22. PubMed ID: 15330743
[TBL] [Abstract][Full Text] [Related]
12. Evolution of physicochemical properties of melanin concentrating hormone receptor 1 (MCHr1) antagonists.
Johansson A
Bioorg Med Chem Lett; 2016 Oct; 26(19):4559-4564. PubMed ID: 27595423
[TBL] [Abstract][Full Text] [Related]
13. Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel 1-(1H-benzimidazol-6-yl)pyridin-2(1H)-one derivatives and design to avoid CYP3A4 time-dependent inhibition.
Igawa H; Takahashi M; Shirasaki M; Kakegawa K; Kina A; Ikoma M; Aida J; Yasuma T; Okuda S; Kawata Y; Noguchi T; Yamamoto S; Fujioka Y; Kundu M; Khamrai U; Nakayama M; Nagisa Y; Kasai S; Maekawa T
Bioorg Med Chem; 2016 Jun; 24(11):2486-2503. PubMed ID: 27112449
[TBL] [Abstract][Full Text] [Related]
14. Promising strategies for obesity pharmacotherapy: melanocortin-4 (MC-4) receptor agonists and melanin concentrating hormone (MCH) receptor-1 antagonists.
Jeon MK; Cheon HG
Curr Top Med Chem; 2009; 9(6):504-38. PubMed ID: 19689363
[TBL] [Abstract][Full Text] [Related]
15. Discovery of orally efficacious melanin-concentrating hormone receptor-1 antagonists as antiobesity agents. Synthesis, SAR, and biological evaluation of bicyclo[3.1.0]hexyl ureas.
McBriar MD; Guzik H; Shapiro S; Paruchova J; Xu R; Palani A; Clader JW; Cox K; Greenlee WJ; Hawes BE; Kowalski TJ; O'neill K; Spar BD; Weig B; Weston DJ; Farley C; Cook J
J Med Chem; 2006 Apr; 49(7):2294-310. PubMed ID: 16570926
[TBL] [Abstract][Full Text] [Related]
16. Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists.
Kym PR; Iyengar R; Souers AJ; Lynch JK; Judd AS; Gao J; Freeman J; Mulhern M; Zhao G; Vasudevan A; Wodka D; Blackburn C; Brown J; Che JL; Cullis C; Lai SJ; LaMarche MJ; Marsilje T; Roses J; Sells T; Geddes B; Govek E; Patane M; Fry D; Dayton BD; Brodjian S; Falls D; Brune M; Bush E; Shapiro R; Knourek-Segel V; Fey T; McDowell C; Reinhart GA; Preusser LC; Marsh K; Hernandez L; Sham HL; Collins CA
J Med Chem; 2005 Sep; 48(19):5888-91. PubMed ID: 16161992
[TBL] [Abstract][Full Text] [Related]
17. Melanin-Concentrating Hormone Receptor 1 Antagonists Lacking an Aliphatic Amine: Synthesis and Structure-Activity Relationships of Novel 1-(Imidazo[1,2-a]pyridin-6-yl)pyridin-2(1H)-one Derivatives.
Igawa H; Takahashi M; Kakegawa K; Kina A; Ikoma M; Aida J; Yasuma T; Kawata Y; Ashina S; Yamamoto S; Kundu M; Khamrai U; Hirabayashi H; Nakayama M; Nagisa Y; Kasai S; Maekawa T
J Med Chem; 2016 Feb; 59(3):1116-39. PubMed ID: 26736071
[TBL] [Abstract][Full Text] [Related]
18. Building a MCHR1 homology model provides insight into the receptor-antagonist contacts that are important for the development of new anti-obesity agents.
Cirauqui N; Schrey AK; Galiano S; Ceras J; Pérez-Silanes S; Aldana I; Monge A; Kühne R
Bioorg Med Chem; 2010 Nov; 18(21):7365-79. PubMed ID: 20932767
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Antiobesity Properties of 6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one (BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 (MCHR1) Inhibitor.
Ahmad S; Washburn WN; Hernandez AS; Bisaha S; Ngu K; Wang W; Pelleymounter MA; Longhi D; Flynn N; Azzara AV; Rohrbach K; Devenny J; Rooney S; Thomas M; Glick S; Godonis H; Harvey S; Zhang H; Gemzik B; Janovitz EB; Huang C; Zhang L; Robl JA; Murphy BJ
J Med Chem; 2016 Oct; 59(19):8848-8858. PubMed ID: 27564419
[TBL] [Abstract][Full Text] [Related]
20. Melanin-concentrating hormone receptor 1 antagonists. Synthesis and structure-activity relationships of novel 3-(aminomethyl)quinolines.
Kamata M; Yamashita T; Imaeda T; Tanaka T; Masada S; Kamaura M; Kasai S; Hara R; Sasaki S; Takekawa S; Asami A; Kaisho T; Suzuki N; Ashina S; Ogino H; Nakano Y; Nagisa Y; Kato K; Kato K; Ishihara Y
J Med Chem; 2012 Mar; 55(5):2353-66. PubMed ID: 22309223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
